Skip to main content
. Author manuscript; available in PMC: 2023 Mar 14.
Published in final edited form as: Paediatr Drugs. 2022 Mar 14;24(2):163–173. doi: 10.1007/s40272-022-00493-3

Table 2.

Selected Covariate Models Evaluated

Covariate model Covariance CL, V −2LL Δ−2LL Comment
None Yes −77.167 Base model
WT on V No −69.784 +7.383 Did not converge
WT on V Yes −73.998 +3.169 Did not converge, covariance term not estimable
WT on CL No −81.188 −4.021
WT on CL Yes −82.204 −5.037 Did not converge
LBW on CL and V No −83.288 −6.121
WT on CL and V No −84.218 −7.051 Final model
WT on CL and V Yes −84.469 −7.302 Covariance term implausible
CLcr on CLr 1 No −87.277 −10.11 IIV CL not estimable (estimated at 1%, biologically implausible), covariance step aborted
CLcr on CLr 3 No −87.803 −10.64 IIV CL not estimable, covariance step aborted
CLcr on CLr 2 No −90.256 −13.09 Did not converge, IIV CL not estimable

Covariate models including WT or LBW had fixed allometric exponents; therefore, no degrees of freedom were added.

CL, clearance; CLcr, creatinine clearance; CLr, renal clearance; IIV, inter-individual variability; LBW, lean body weight; TBW, total body weight; V, volume of distribution; −2LL, objective function value; Δ−2LL, change in objective function value